Objectives: MDCO216 is a complex of dimeric apoA-IMilano (apoA-IM) and POPC, shown to reduce
atherosclerotic plaque burden. Here we studied the effect of incubation of human plasma
or serum with MDCO216 on cholesterol efflux capacity from J774 cells, as well as on
various HDL subfractions measured by ELISA, 2D-electrophoresis and NMR.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
EAS-0865
Identification
Copyright
© 2014 Published by Elsevier Inc.
